Eric Ostertag
Founder at Demeetra AgBio, Inc.
Net worth: 19 M $ as of 2024-03-30
Profile
Eric M.
Ostertag is the founder of Transposagen Biopharmaceuticals, Inc. (founded in 2003), Vindico NanoBioTechnology LLC (founded in 2008), PhenoTech, Inc. (founded in 2003), and Poseida Therapeutics, Inc. (founded in 2014).
He held the position of President & Chief Executive Officer at Transposagen Biopharmaceuticals, Inc. and Vindico NanoBioTechnology LLC, and Executive Vice President-Research at PhenoTech, Inc. Currently, he is a Director at Hera Testing Laboratories, Inc. Dr. Ostertag received a doctorate degree from the University of Pennsylvania in 2002 and an undergraduate degree from the University of Wisconsin in 1995.
Dr. Ostertag is also the founder of Hera BioLabs, Demeetra AgBio, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-03-14 | 6,028,560 ( 6.25% ) | 19 M $ | 2024-03-30 |
Eric Ostertag active positions
Companies | Position | Start |
---|---|---|
Hera Testing Laboratories, Inc.
Hera Testing Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Hera Testing Laboratories, Inc. develops preclinical drugs for vivo and vitro toxicology. The company was founded in 2014 and is headquartered in Lexington, KY. | Director/Board Member | - |
Hera BioLabs
Hera BioLabs Miscellaneous Commercial ServicesCommercial Services Hera BioLabs is a preclinical service and technology provider that offers genetic engineering and animal model creation technologies. Hera conducts all work with excellent scientific rigor and customer service at their laboratories, which include an AAALAC-accredited state-of-the-art vivarium, centrally located in Kentucky. The American company created the SRG™ rat, the first commercially available highly immunocompromised rat model validated for human tumor xenograft studies. Hera has its own proprietary genetic engineering technologies, the PiggyBac® DNA delivery system and the Cas-CLOVER™ site-specific nuclease system platforms used for cell line modification and animal model creation. The company provides researchers in industry and academia with genetic engineering technologies and related products, as well as services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. The company was founded by Eric M. Ostertag. | Founder | - |
Demeetra AgBio, Inc.
Demeetra AgBio, Inc. Miscellaneous Commercial ServicesCommercial Services Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford. | Founder | - |
Former positions of Eric Ostertag
Companies | Position | End |
---|---|---|
POSEIDA THERAPEUTICS, INC. | Chief Executive Officer | 2022-01-31 |
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Chief Executive Officer | 2015-06-30 |
Vindico NanoBioTechnology LLC
Vindico NanoBioTechnology LLC BiotechnologyHealth Technology Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA. | Chief Executive Officer | 2015-06-30 |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Founder | 2006-12-31 |
Training of Eric Ostertag
University of Pennsylvania | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
POSEIDA THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Transposagen Biopharmaceuticals, Inc.
Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY. | Health Technology |
Hera Testing Laboratories, Inc.
Hera Testing Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Hera Testing Laboratories, Inc. develops preclinical drugs for vivo and vitro toxicology. The company was founded in 2014 and is headquartered in Lexington, KY. | Health Technology |
Vindico NanoBioTechnology LLC
Vindico NanoBioTechnology LLC BiotechnologyHealth Technology Vindico NanoBioTechnology LLC develops novel and life-saving therapies. The company is headquartered in San Diego, CA. | Health Technology |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Health Technology |
Hera BioLabs
Hera BioLabs Miscellaneous Commercial ServicesCommercial Services Hera BioLabs is a preclinical service and technology provider that offers genetic engineering and animal model creation technologies. Hera conducts all work with excellent scientific rigor and customer service at their laboratories, which include an AAALAC-accredited state-of-the-art vivarium, centrally located in Kentucky. The American company created the SRG™ rat, the first commercially available highly immunocompromised rat model validated for human tumor xenograft studies. Hera has its own proprietary genetic engineering technologies, the PiggyBac® DNA delivery system and the Cas-CLOVER™ site-specific nuclease system platforms used for cell line modification and animal model creation. The company provides researchers in industry and academia with genetic engineering technologies and related products, as well as services in these areas, performing cell engineering and in vitro and in vivo oncology studies for clients. The company was founded by Eric M. Ostertag. | Commercial Services |
Demeetra AgBio, Inc.
Demeetra AgBio, Inc. Miscellaneous Commercial ServicesCommercial Services Demeetra AgBio, Inc. is an American biotechnology company that specializes in gene editing. Demeetra AgBio is located in a hub for agbiotech and is centrally located in the bluegrass state. The company has built extensive gene editing know-how and has a scientific team composed of experts with diverse backgrounds in gene editing. The company's scientific achievements include being the first to successfully edit plants and yeast with their precise cas-clover technology. Demeetra AgBio's primary focus is on engineering traits for life with advanced gene-editing technologies cas-clover & piggybac transposase. The company was founded in 2019 by Eric M. Ostertag and is currently led by CEO Jack Crawford. | Commercial Services |
- Stock Market
- Insiders
- Eric Ostertag